MY7400317A - Halogeno-pregnadienes and process for the manufacture thereof - Google Patents

Halogeno-pregnadienes and process for the manufacture thereof

Info

Publication number
MY7400317A
MY7400317A MY317/74A MY7400317A MY7400317A MY 7400317 A MY7400317 A MY 7400317A MY 317/74 A MY317/74 A MY 317/74A MY 7400317 A MY7400317 A MY 7400317A MY 7400317 A MY7400317 A MY 7400317A
Authority
MY
Malaysia
Prior art keywords
pregnadienes
halogeno
manufacture
Prior art date
Application number
MY317/74A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MY7400317A publication Critical patent/MY7400317A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R33/00—Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
MY317/74A 1967-11-17 1974-12-30 Halogeno-pregnadienes and process for the manufacture thereof MY7400317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Publications (1)

Publication Number Publication Date
MY7400317A true MY7400317A (en) 1974-12-31

Family

ID=4414467

Family Applications (1)

Application Number Title Priority Date Filing Date
MY317/74A MY7400317A (en) 1967-11-17 1974-12-30 Halogeno-pregnadienes and process for the manufacture thereof

Country Status (15)

Country Link
US (1) US3652554A (de)
JP (1) JPS4829221B1 (de)
AT (3) AT298690B (de)
BE (1) BE723905A (de)
BR (1) BR6804024D0 (de)
CH (4) CH510655A (de)
DK (1) DK129835B (de)
FR (2) FR1594773A (de)
GB (1) GB1245292A (de)
MY (1) MY7400317A (de)
NL (1) NL161767C (de)
PL (1) PL80570B1 (de)
SE (1) SE351634B (de)
SU (1) SU424352A3 (de)
YU (4) YU34138B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide
CH558787A (de) * 1970-12-10 1975-02-14 Ciba Geigy Ag Verfahren zur herstellung eines neuen halogenpregnadiens.
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
GB1505701A (en) * 1975-06-14 1978-03-30 Pierrel Spa 2-chloro-6beta-fluoropregnanes
FR2291760A1 (fr) * 1974-11-19 1976-06-18 Pierrel Spa Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (de) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (de) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Zusammensetzungen von phosphodiesterase-typ-iv-hemmern
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
CN102827229B (zh) * 2011-06-17 2016-01-20 重庆华邦胜凯制药有限公司 一种纯化卤米松羧酸酯的方法
CN104370987B (zh) * 2014-10-22 2016-09-14 湖南明瑞制药有限公司 一种卤米松的精制方法
CN111944004B (zh) * 2020-09-25 2023-11-17 湖南新合新生物医药有限公司 一种卤米松的制备方法

Also Published As

Publication number Publication date
GB1245292A (en) 1971-09-08
US3652554A (en) 1972-03-28
CH513845A (de) 1971-10-15
NL6816337A (de) 1969-05-20
JPS4829221B1 (de) 1973-09-08
YU267368A (en) 1978-06-30
PL80570B1 (de) 1975-08-30
DE1807980B2 (de) 1975-11-06
NL161767C (nl) 1980-03-17
FR8278M (de) 1970-11-02
SE351634B (de) 1972-12-04
CH540244A (de) 1973-08-15
CH510655A (de) 1971-07-31
YU30675A (en) 1982-05-31
YU30775A (en) 1982-05-31
FR1594773A (de) 1970-06-08
AT293633B (de) 1971-10-25
AT298695B (de) 1972-05-25
YU34138B (en) 1978-12-31
DE1807980A1 (de) 1969-06-04
YU30875A (en) 1982-05-31
CH534144A (de) 1973-02-28
DK129835B (da) 1974-11-25
AT298690B (de) 1972-04-15
DK129835C (de) 1975-05-05
SU424352A3 (de) 1974-04-15
BR6804024D0 (pt) 1973-01-02
BE723905A (de) 1969-05-14

Similar Documents

Publication Publication Date Title
IL30429A (en) Isothiocyanatobenzazoles and processes for the production thereof
MY7400317A (en) Halogeno-pregnadienes and process for the manufacture thereof
IL31197A0 (en) Epoxy compounds and process for the manufacture thereof
IL30350A0 (en) Benzodiazepine derivatives and process for the manufacture thereof
MTP565B (en) Sermentation process
IL30346A0 (en) Tricyclic compounds and process for the manufacture thereof
IL31188A0 (en) Epoxides and process for the manufacture thereof
IL30911A0 (en) Tetrahydroisoquinoline derivatives and process for the manufacture thereof
IL29772A0 (en) Benzodiazepine derivatives and process for the manufacture thereof
CY753A (en) Process for the manufacture of alpha-thyrocalcitonin and beta-thyrocalcitonin
IL30487A0 (en) Tetrahydroisoquinoline derivatives and process for the manufacture thereof
MY7100109A (en) Benzenesulphonyl-ureas and process for preparing the
IL31224A0 (en) Epoxy compounds and process for the manufacture thereof
IE32263B1 (en) Benzodiazepine derivatives and process for the manufacture thereof
IL30879A0 (en) 4-oxa-androstanes and process for the manufacture thereof
IL28748A (en) N1-isoxazolyl-sulfanilamides and process for the manufacture thereof
IL31159A0 (en) New substituted benzamidines and process for the preparation thereof
CA752405A (en) Aminoisoxazoles and process for the manufacture thereof
CA759993A (en) Polyeneketones and process for the manufacture thereof
CA756609A (en) Azapentanols and process for the manufacture thereof
IL29884A0 (en) Novel 1-sec-aminocyclopropacyclo-alkanes and process for making them
IL24853A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL24852A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
PH9259A (en) 3-4-0-arylidene 7-halo-7-deoxy-lincomycin-2-acylates and process for the preparation thereof
IL29927A0 (en) Process for manufacturing 2,6-dichloro-benzamide and the 2,6-dichlorobenzo-nitrile that can be obtained therefrom